THCV

In the latest episode of Benzinga’s Cannabis Insider, Phylos chief commercial officer Whitney Conroy shared groundbreaking developments in Phylos’ elite F1 hybrid seeds and their significant advancements in THCV research. Phylos, a company leading in cannabis genetics and sustainable...

Cannabis genetics company Phylos, in partnership with People Science, conducted an Institutional Review Board-approved, double-blind clinical study on the effects of rare cannabinoid tetrahydrocannabivarin (THCV). According to the research, Natural Natural THCV developed by Phylos resulted in...

As the cannabis industry ushers in the festive spirit of the holidays, innovative and exciting new products are dazzling the market. From limited-edition sparkling champagne chews to THC gummies with rapid-release technology, the cannabis landscape is aglow with diverse offerings. See...

In 1970, University of Oxford researchers unveiled the discovery of tetrahydrocannabivarin (THCV), a unique cannabis compound distinct from the well-known THC and CBD. For decades, its elusive nature conferred it a legendary status, earning denominations like “the sports car of weed” or...

The cannabis industry is witnessing an array of exciting new cannabis products, as leading players introduce groundbreaking developments that redefine the way we experience cannabis. From innovative pre-roll flavors and limited-time collections to refreshing CBD-infused beverages and unique strains...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands. The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the...

CBD Move Free has partnered with Arbor Hemp, a hemp company offering clinically studied plant-sourced solutions. The partnership will initially result in the launch of two co-branded products, Sleep Soft Gels and Slim Soft Gels, which are geared toward those looking to improve sleep and curb...

This article was originally published on Cannabis.net and appears here with permission. A lot of cannabis users are very familiar with Delta 9 THC and the effects it has on our bodies and mind. At a basic level, an average cannabis consumer recognizes that the major psychoactive compound present in...

Radicle Science will launch large-scale, blinded, placebo-controlled clinical trials on rare cannabinoids including THCV, CBN, CBG, and CBC, to study their effects on energy, focus, appetite, sleep disturbance, pain, stress, and anxiety. These unprecedented Radicle Discovery studies will involve...

Original publication date: November 9, 2020 4:30 pm Much of cannabis’ disruptive potential lies in the plant’s ability to produce cannabinoids like THC and CBD. When it comes to rare cannabinoids, however, a different approach might yield better results. Scientists have found...

By WeedMaps News' Tyler Koslow, provided exclusively to Benzinga Cannabis. 2019 has the potential to be remembered as the year when minor cannabinoids really hit the scene. While it's true that the cannabis market is generally interested in tetrahydrocannabinol (THC), the intoxicating...